Chapter 14 • Cancer remains a major cause of mortality among patients with primary and acquired immunodeficiencies. • Cancer in immunocompromised hosts is frequently associated with infectious agents, including the following: Epstein-Barr virus (associated with lymphoproliferative disorders and leiomyosarcoma) Human herpesvirus 8 (associated with Kaposi sarcoma, Castleman disease, and pleural-based effusion lymphoma) Human papillomavirus (associated with skin anal and cervical carcinomas) • Categories of genetic immunodeficiencies with increased risk of the development of cancer include the following: Combined defects with T-cell dysfunction (e.g., severe combined immunodeficiency or Wiskott-Aldrich syndrome) Defects that inhibit lymphoid apoptosis (e.g., autoimmune lymphoproliferative syndrome) Defects of genomic instability (e.g., ataxia telangiectasia) Acquired deficiencies in T-cell immunity with increased risk of developing cancer, such as:
Immunodeficiency and Cancer
Summary of Key Points
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree